3,074 hedge funds and large institutions have $169B invested in Pfizer in 2022 Q3 according to their latest regulatory filings, with 138 funds opening new positions, 1,352 increasing their positions, 1,226 reducing their positions, and 168 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

less funds holding

Funds holding:

16% less capital invested

Capital invested by funds: $201B → $169B (-$32B)

18% less first-time investments, than exits

New positions opened: 138 | Existing positions closed: 168

38% less funds holding in top 10

Funds holding in top 10: 251156 (-95)

Holders
3,074
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
156
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.73B
Puts
$2.07B
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
2026
$753K
2027
$753K
2028
$753K
2029
$752K
2030
$752K
2031
$752K
2032
$751K
2033
$751K
2034
$751K
2035
$749K
2036
$749K
2037
$748K
2038
$748K
2039
$747K
2040
$745K
2041
$745K
2042
$744K
2043
$743K
2044
$743K
2045
$742K
2046
$741K
2047
$740K
2048
$739K
2049
$737K
2050
$736K